Brigham researchers are working on a new approach to target autoimmunity in the brain leverages designer bacteria to make treatment safer and more effective.
All About the New Ketamine Trial at the University of Otago | Psychedelic Invest
Depression remains one of the most challenging mental health conditions, affecting millions worldwide with varying degrees of severity. Traditional treatments like psychotherapy and antidepressants are
April 12, 2024